Tesamorelin, liver fat, and NAFLD in the setting of HIV

Affiliations

• ¹ The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC 3000, Australia.
• ² The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC 3000, Australia; Department of Infectious Diseases, Monash University and Alfred Hospital, Melbourne, VIC, Australia; Victorian Infectious Disease Service, Royal Melbourne Hospital, Doherty Institute, Melbourne, VIC, Australia.
• ³ The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC 3000, Australia; Department of Infectious Diseases, Monash University and Alfred Hospital, Melbourne, VIC, Australia. Electronic address: sharon.lewin@unimelb.edu.au.